Literature DB >> 33538539

Risk Factors for Severe COVID-19 in Children.

Kelly Graff1, Christiana Smith1, Lori Silveira1, Sarah Jung2, Shane Curran-Hays1, Jane Jarjour1, Lauren Carpenter3, Kasey Pickard3, Michael Mattiucci1, JoEllen Fresia3, Elizabeth J McFarland1, Samuel R Dominguez1,2, Lisa Abuogi1.   

Abstract

BACKGROUND: There are limited pediatric data regarding severe COVID-19 disease. Our study aims to describe the epidemiology and identify risk factors for severe COVID-19 disease in children.
METHODS: This is a retrospective cohort study among children with positive SARS-CoV-2 PCR from March to July 2020 at Children's Hospital Colorado. Risk factors for severe disease were analyzed as defined by hospital admission, respiratory support, or critical care. Univariable and multivariable analyses were conducted.
RESULTS: Among 454 patients identified with SARS-CoV-2, 191 (42.1%) were females, median age 11 years. Fifty-five percent of all patients identified as Hispanic compared with 29% among all hospital visits in 2019 (P < 0.0001). In multivariable analyses, age 0-3 months or >20 years [adjusted odds ratio (aOR), 7.85; P < 0.0001 and aOR, 5.1; P = 0.03, respectively], preterm birth history (aOR, 3.7; P = 0.03), comorbidities [including immunocompromise (aOR, 3.5; P = 0.004), gastrointestinal condition (aOR, 2.7; P = 0.009), diabetes (aOR, 6.6; P = 0.04), asthma (aOR, 2.2; P = 0.04)], and specific symptoms at presentation were predictors for admission. Age 0-3 months or >20 years, asthma, gastrointestinal condition, and similar symptoms at presentation were also predictors for respiratory support. Elevated C-reactive protein was associated with the need for critical care with median of 17.7 mg/dL (IQR, 5.3-22.9) versus 1.95 mg/dL (IQR, 0.7-5.5) among patients requiring critical versus no critical care (OR, 1.2; P = 0.02).
CONCLUSIONS: Extremes of age, comorbid conditions, and elevated CRP are predictors of severe disease in children. Findings from this study can inform pediatric providers and public health officials to tailor clinical management, pandemic planning, and resource allocation.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33538539     DOI: 10.1097/INF.0000000000003043

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  53 in total

1.  The feasibility, safety, and efficacy of Paxlovid treatment in SARS-CoV-2-infected children aged 6-14 years: a cohort study.

Authors:  Gangfeng Yan; Jianguo Zhou; Haitao Zhu; Yiwei Chen; Yanming Lu; Ting Zhang; Hui Yu; Libo Wang; Hong Xu; Zheng Wang; Wenhao Zhou
Journal:  Ann Transl Med       Date:  2022-06

2.  Clinical Factors Associated with COVID-19 Severity in Chronic Hospitalized Infants and Toddlers: Data from a Center in the West Part of Romania.

Authors:  Alina Domnicu; Mirela Mogoi; Aniko Manea; Eugen Radu Boia; Marioara Boia
Journal:  Healthcare (Basel)       Date:  2022-04-27

3.  Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases.

Authors:  Napaporn Chantasrisawad; Thanyawee Puthanakit; Auchara Tangsathapornpong; Chonnamet Techasaensiri; Wanatpreeya Phongsamart; Detchvijitr Suwanpakdee; Peera Jaruampornpan; Jiratchaya Sophonphan; Piyarat Suntarattiwong; Tawee Chotpitayasunondh
Journal:  Vaccines (Basel)       Date:  2022-05-29

4.  Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.

Authors:  Karrie K K Ko; Hatairat Yingtaweesittikul; Thuan Tong Tan; Limin Wijaya; Delphine Yanhong Cao; Sui Sin Goh; Nurdyana Binte Abdul Rahman; Kenneth X L Chan; Hui Ming Tay; James Heng Chiak Sim; Kian Sing Chan; Lynette L E Oon; Niranjan Nagarajan; Chayaporn Suphavilai
Journal:  Microbiol Spectr       Date:  2022-05-11

5.  Risk Factors for Severe COVID-19 in Children.

Authors:  Rebecca C Woodruff; Angela P Campbell; Christopher A Taylor; Shua J Chai; Breanna Kawasaki; James Meek; Evan J Anderson; Andy Weigel; Maya L Monroe; Libby Reeg; Erica Bye; Daniel M Sosin; Alison Muse; Nancy M Bennett; Laurie M Billing; Melissa Sutton; H Keipp Talbot; Keegan McCaffrey; Huong Pham; Kadam Patel; Michael Whitaker; Meredith L McMorrow; Fiona P Havers
Journal:  Pediatrics       Date:  2021-12-22       Impact factor: 9.703

6.  Does vaccinating adults stop kids from spreading COVID too?

Authors:  Dyani Lewis
Journal:  Nature       Date:  2021-06       Impact factor: 49.962

7.  Asthma is associated with lower respiratory tract involvement and worse clinical score in children with COVID-19.

Authors:  Anna Clara Rabha; Fátima Rodrigues Fernandes; Dirceu Solé; Leonard Benjamin Bacharier; Gustavo Falbo Wandalsen
Journal:  Pediatr Allergy Immunol       Date:  2021-05-29       Impact factor: 5.464

8.  Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.

Authors:  Maala Bhatt; Amy C Plint; Ken Tang; Richard Malley; Anne Pham Huy; Candice McGahern; Jennifer Dawson; Martin Pelchat; Lauren Dawson; Terry Varshney; Corey Arnold; Yannick Galipeau; Michael Austin; Nisha Thampi; Fuad Alnaji; Marc-André Langlois; Roger L Zemek
Journal:  CMAJ Open       Date:  2022-04-12

9.  COVID-19 Pneumonia and Status Asthmaticus With Respiratory Failure in a Pediatric Patient: A Simulation for Emergency Medicine Providers.

Authors:  Hoi See Tsao; Mariann Nocera Kelley; Lauren Allister; Robyn Wing
Journal:  MedEdPORTAL       Date:  2022-01-21

10.  COVID-19: Critical appraisal of the evidence.

Authors:  Paz González Rodríguez; Begoña Pérez-Moneo Agapito; María Salomé Albi Rodríguez; Pilar Aizpurua Galdeano; María Aparicio Rodrigo; María Mercedes Fernández Rodríguez; María Jesús Esparza Olcina; Carlos Ochoa Sangrador
Journal:  An Pediatr (Engl Ed)       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.